J7213 HCPCS Level II code: Injection, coagulation factor ix (recombinant), ixinity, 1 i.u.
J7213 is the HCPCS code for “Injection, coagulation factor ix (recombinant), ixinity, 1 i.u.” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J7213Injection, coagulation factor ix (recombinant), ixinity, 1 i.u.
Short description: Inj, ixinity, 1 i.u.
HCPCS · United States
Medicare details
The indicators CMS publishes with J7213 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care
- BETOS category
- Other drugs
- Added
- Jul 1, 2023
Where J7213 sits
- 1J codesDrugs administered other than orally
- 2Active code J7213Injection, coagulation factor ix (recombinant), ixinity, 1 i.u.
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J7213 mean?
J7213 is the HCPCS code for “Injection, coagulation factor ix (recombinant), ixinity, 1 i.u.” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J7213?
CMS lists J7213’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J7213
All J codesJ7207Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u.J7208Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, (jivi), 1 i.u.J7209Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u.J7210Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u.J7211Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u.J7212Factor viia (antihemophilic factor, recombinant)-jncw (sevenfact), 1 microgramJ7214Injection, factor viii/von willebrand factor complex, recombinant (altuviiio), per factor viii i.u.J7294Segesterone acetate and ethinyl estradiol 0.15mg, 0.013mg per 24 hours; yearly vaginal system, eachJ7295Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, eachJ7296Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mgJ7297Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mgJ7298Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg